BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO

Podobné jednotky

• CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
  Autor: Hammitzsch, A, a další
  Vydáno: (2015)
• Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
  Autor: Hammitzsch, A, a další
  Vydáno: (2018)
• miR-10b-5p is a novel Th17 regulator present in Th17 cells from Ankylosing Spondylitis
  Autor: Chen, L, a další
  Vydáno: (2017)
• The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis
  Autor: Al-Mossawi, M, a další
  Vydáno: (2013)
• The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.
  Autor: Al-Mossawi, M, a další
  Vydáno: (2013)